• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.双峰HIV包膜DNA加蛋白质疫苗接种产生强效、保护性抗HIV免疫反应。
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83. doi: 10.1073/pnas.94.17.9378.
2
Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.恒河猴对低致病性猿猴-人类免疫缺陷病毒感染的保护作用:与中和抗体和细胞毒性T细胞的相关性
J Virol. 2005 Mar;79(6):3358-69. doi: 10.1128/JVI.79.6.3358-3369.2005.
3
Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.异源包膜免疫原有助于恒河猴的艾滋病疫苗保护。
J Virol. 2004 Jul;78(14):7490-7. doi: 10.1128/JVI.78.14.7490-7497.2004.
4
Multiclade human immunodeficiency virus type 1 envelope immunogens elicit broad cellular and humoral immunity in rhesus monkeys.多分支1型人类免疫缺陷病毒包膜免疫原在恒河猴中引发广泛的细胞免疫和体液免疫。
J Virol. 2005 Mar;79(5):2956-63. doi: 10.1128/JVI.79.5.2956-2963.2005.
5
Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.用表达1型人类免疫缺陷病毒包膜糖蛋白的猿猴免疫缺陷病毒保护感染猴免疫缺陷病毒(SIVmac)的猕猴免受重复感染。
AIDS Res Hum Retroviruses. 1997 Jul 20;13(11):913-22. doi: 10.1089/aid.1997.13.913.
6
Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts.
Virology. 1998 Oct 25;250(2):293-301. doi: 10.1006/viro.1998.9379.
7
Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.用重组卡介苗(Mycobacterium bovis bacillus Calmette-Guérin)Env V3免疫恒河猴,可引发中和抗体介导的针对猿猴-人类免疫缺陷病毒的保护作用,该保护作用针对具有同源而非异源V3基序的病毒。
J Virol. 2005 Feb;79(3):1452-62. doi: 10.1128/JVI.79.3.1452-1462.2005.
8
A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.一种具有复制能力的腺病毒-人类免疫缺陷病毒(Ad-HIV)tat和Ad-HIV env启动/Tat及包膜蛋白加强免疫方案,在恒河猴中对猿猴/人类免疫缺陷病毒SHIV89.6P攻击引发了增强的保护效力。
J Virol. 2007 Apr;81(7):3414-27. doi: 10.1128/JVI.02453-06. Epub 2007 Jan 17.
9
Cytotoxic T lymphocyte and antibody responses generated in rhesus monkeys immunized with retroviral vector-transduced fibroblasts expressing human immunodeficiency virus type-1 IIIB ENV/REV proteins.用表达人免疫缺陷病毒1型IIIB株包膜/反式激活蛋白的逆转录病毒载体转导的成纤维细胞免疫恒河猴后产生的细胞毒性T淋巴细胞和抗体反应。
Hum Gene Ther. 1994 Jul;5(7):853-62. doi: 10.1089/hum.1994.5.7-853.
10
Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.感染猿猴-人类免疫缺陷病毒的恒河猴体内的1型人类免疫缺陷病毒包膜糖蛋白特异性细胞毒性T淋巴细胞
Virology. 1995 Apr 20;208(2):770-5. doi: 10.1006/viro.1995.1209.

引用本文的文献

1
Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines.腺苷脱氨酶-1 增强了 HIV-1 包膜 DNA 和蛋白疫苗的生发中心形成和功能性抗体反应。
Vaccine. 2020 May 8;38(22):3821-3831. doi: 10.1016/j.vaccine.2020.03.047. Epub 2020 Apr 10.
2
Strategies for inducing effective neutralizing antibody responses against HIV-1.诱导针对 HIV-1 的有效中和抗体反应的策略。
Expert Rev Vaccines. 2019 Nov;18(11):1127-1143. doi: 10.1080/14760584.2019.1690458. Epub 2019 Dec 2.
3
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.用gp140进行序贯免疫可增强未感染HIV的南非参与者中由安卡拉痘苗病毒或DNA引发的免疫反应。
PLoS One. 2016 Sep 1;11(9):e0161753. doi: 10.1371/journal.pone.0161753. eCollection 2016.
4
DNA/MVA Vaccines for HIV/AIDS.用于治疗艾滋病毒/艾滋病的DNA/改良痘苗病毒疫苗
Vaccines (Basel). 2014 Feb 28;2(1):160-78. doi: 10.3390/vaccines2010160.
5
DNA Immunization for HIV Vaccine Development.用于HIV疫苗开发的DNA免疫接种
Vaccines (Basel). 2014 Feb 25;2(1):138-59. doi: 10.3390/vaccines2010138.
6
The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.可扩展记忆性CD8+ T细胞的广度与HIV精英控制者体内的残余病毒载量呈负相关。
J Virol. 2015 Nov;89(21):10735-47. doi: 10.1128/JVI.01527-15. Epub 2015 Aug 12.
7
Macaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors.猴免疫缺陷病毒 1 型:突破宿主限制因子。
Front Microbiol. 2013 Jul 9;4:187. doi: 10.3389/fmicb.2013.00187. eCollection 2013.
8
Synthetic DNA vaccine strategies against persistent viral infections.针对持续性病毒感染的合成 DNA 疫苗策略。
Expert Rev Vaccines. 2013 May;12(5):537-54. doi: 10.1586/erv.13.33.
9
Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.天然减毒山羊关节炎脑炎病毒(CAEV)5'LTR 驱动的慢病毒 DNA 疫苗在小鼠和猕猴中的免疫原性。
Vaccine. 2012 Apr 19;30(19):2956-62. doi: 10.1016/j.vaccine.2012.02.050. Epub 2012 Mar 2.
10
α1Proteinase inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 disease.α1 蛋白酶抑制剂调节 CD4+ 淋巴细胞水平,是 HIV-1 疾病中的限速因子。
PLoS One. 2012;7(2):e31383. doi: 10.1371/journal.pone.0031383. Epub 2012 Feb 17.

本文引用的文献

1
HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.给恒河猴接种的HIV-1包膜DNA疫苗可引发分泌γ干扰素和肿瘤坏死因子-α的MHC II类限制性CD4+辅助性T细胞。
J Immunol. 1997 May 1;158(9):4471-7.
2
Humoral and cellular immunities elicited by HIV-1 vaccination.
J Pharm Sci. 1996 Dec;85(12):1317-24. doi: 10.1021/js9600991.
3
Vaccination of mice and nonhuman primates using HIV-gene-containing DNA.使用含HIV基因的DNA对小鼠和非人类灵长类动物进行疫苗接种。
Antibiot Chemother (1971). 1996;48:100-4. doi: 10.1159/000425163.
4
An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.源自1型原发性人类免疫缺陷病毒分离株的env基因赋予嵌合猿猴/人类免疫缺陷病毒在恒河猴体内高复制能力。
J Virol. 1996 May;70(5):3198-206. doi: 10.1128/JVI.70.5.3198-3206.1996.
5
Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.用重组gp120SF2免疫的黑猩猩对HIV-1SF2攻击的抵抗力。
AIDS. 1995 Dec;9(12):1313-22. doi: 10.1097/00002030-199512000-00003.
6
Cytotoxic T lymphocyte and helper T cell responses following HIV polynucleotide vaccination.HIV多核苷酸疫苗接种后的细胞毒性T淋巴细胞和辅助性T细胞反应。
Ann N Y Acad Sci. 1995 Nov 27;772:198-208. doi: 10.1111/j.1749-6632.1995.tb44745.x.
7
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.用MN-rgp120免疫的黑猩猩对人免疫缺陷病毒1型原代分离株的异源感染具有保护作用。
J Infect Dis. 1996 Jan;173(1):52-9. doi: 10.1093/infdis/173.1.52.
8
Gene inoculation generates immune responses against human immunodeficiency virus type 1.基因接种可引发针对1型人类免疫缺陷病毒的免疫反应。
Proc Natl Acad Sci U S A. 1993 May 1;90(9):4156-60. doi: 10.1073/pnas.90.9.4156.
9
Heterologous protection against influenza by injection of DNA encoding a viral protein.通过注射编码病毒蛋白的DNA实现对流感的异源保护。
Science. 1993 Mar 19;259(5102):1745-9. doi: 10.1126/science.8456302.
10
Vaccines against human immunodeficiency virus--progress and prospects.抗人类免疫缺陷病毒疫苗——进展与前景
N Engl J Med. 1993 Nov 4;329(19):1400-5. doi: 10.1056/NEJM199311043291908.

双峰HIV包膜DNA加蛋白质疫苗接种产生强效、保护性抗HIV免疫反应。

Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination.

作者信息

Letvin N L, Montefiori D C, Yasutomi Y, Perry H C, Davies M E, Lekutis C, Alroy M, Freed D C, Lord C I, Handt L K, Liu M A, Shiver J W

机构信息

Harvard Medical School, Beth Israel Hospital, Boston, MA 02215, USA.

出版信息

Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9378-83. doi: 10.1073/pnas.94.17.9378.

DOI:10.1073/pnas.94.17.9378
PMID:9256490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC23198/
Abstract

It is generally thought that an effective vaccine to prevent HIV-1 infection should elicit both strong neutralizing antibody and cytotoxic T lymphocyte responses. We recently demonstrated that potent, boostable, long-lived HIV-1 envelope (Env)-specific cytotoxic T lymphocyte responses can be elicited in rhesus monkeys using plasmid-encoded HIV-1 env DNA as the immunogen. In the present study, we show that the addition of HIV-1 Env protein to this regimen as a boosting immunogen generates a high titer neutralizing antibody response in this nonhuman primate species. Moreover, we demonstrate in a pilot study that immunization with HIV-1 env DNA (multiple doses) followed by a final immunization with HIV-1 env DNA plus HIV-1 Env protein (env gene from HXBc2 clone of HIV IIIB; Env protein from parental HIV IIIB) completely protects monkeys from infection after i.v. challenge with a chimeric virus expressing HIV-1 env (HXBc2) on a simian immmunodeficiency virusmac backbone (SHIV-HXBc2). The potent immunity and protection seen in these pilot experiments suggest that a DNA prime/DNA plus protein boost regimen warrants active investigation as a vaccine strategy to prevent HIV-1 infection.

摘要

一般认为,一种有效的预防HIV-1感染的疫苗应能引发强烈的中和抗体和细胞毒性T淋巴细胞反应。我们最近证明,使用质粒编码的HIV-1包膜(Env)DNA作为免疫原,可在恒河猴中引发强效、可增强、持久的HIV-1包膜特异性细胞毒性T淋巴细胞反应。在本研究中,我们表明在此方案中添加HIV-1 Env蛋白作为增强免疫原,可在这种非人灵长类动物中产生高滴度的中和抗体反应。此外,我们在一项初步研究中证明,先用HIV-1 env DNA(多剂)免疫,最后用HIV-1 env DNA加HIV-1 Env蛋白(HIV IIIB的HXBc2克隆的env基因;亲本HIV IIIB的Env蛋白)免疫,在静脉注射用猿猴免疫缺陷病毒-猴空泡病毒(SHIV-HXBc2)骨架表达HIV-1 env(HXBc2)的嵌合病毒攻击后,可完全保护猴子免受感染。这些初步实验中所见的强效免疫和保护作用表明,DNA初免/DNA加蛋白增强方案作为预防HIV-1感染的疫苗策略值得积极研究。